Schedule 13G ownership disclosure
NEUBASE THERAPEUTICS INC
Security class unavailable · CUSIP: 64132K201
Event date: 2023-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 1.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-24-000707
- Form type
- SC 13G
- Filer
- GREENLIGHT CAPITAL INC
- CIK
- CIK 1079114
- Filed
- Feb 14, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership